Ensilication Platform

About EnsiliTech

EnsiliTech is pioneering a novel, patent-protected stabilization platform called ensilication, which protects biomolecules from thermal degradation without requiring a cold chain. The technology addresses a critical global challenge: the estimated 25% vaccine wastage and $35B annual cost due to cold chain failures. As a private, pre-revenue company, EnsiliTech is in the pre-clinical development stage, building partnerships to apply its platform across vaccines, antibodies, and other biologics to improve shelf-life, reduce costs, and lower the carbon footprint of global health programs.

Therapeutic Areas